Raising Biotech - Listen - Raising Biotech

Listen now

More Episodes

6. Alltrna and tRNA therapeutics for rare genetic diseases with CEO Michelle Werner and rare diseases expert Dr David Weinstein

In this episode of Raising Biotech, Surani explores the untapped world of tRNA therapeutics with Flagship Pioneering-founded company Alltrna. The company raised $109 million in a series B in August 2023. Surani talks to CEO Michelle Werner about the inception of Alltrna, the company's tRNA...

Published 12/19/23

5. Arialys and a neuropsychiatry drug revival with CEO Jay Lichter and experts Marty Jefson (Pinteon) and Dr Leon Henderson-MacLennan (InThought)

In this episode of Raising Biotech, Surani delves into Arialys and its mission to revive an autoimmune encephalitis drug from the grave after big pharma no longer wanted it. The company founders are a bunch of venture capitalists (Avalon Ventures, MPM Capital & Catalys Pacific) who saw...

Published 12/12/23

4. Synchron and breakthrough brain implants with CEO Dr Tom Oxley, CCO Kurt Haggstrom and experts Dr Elad Levy (UB), Dr David Putrino (Mount Sinai)

In this episode of Raising Biotech, Surani delves into Synchron and its mission to develop a potential first-in-class implantable brain computer interface (BCI) that allows people with motor impairment to communicate their thoughts through a device. Founded in 2012, Synchron has raised $145...

Published 12/05/23